Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
none appears on more than one
Arghavan Di Rezze, J.D., age 35, is the Chairperson and Chief Executive Officer of Soren Acquisition Corp. (NASDAQ: SORNU), a healthcare-focused special purpose acquisition company incorporated on September 2, 2025, and based in Miami, Florida. She has served as CEO since the company's incorporation and is the managing member of its sponsor, Soren Holdings LLC, through which she holds an indirect interest in founder shares. Di Rezze is also expected to serve as a director of the SPAC. Under her leadership, Soren Acquisition Corp. priced its IPO on January 6, 2026, and closed its offering on January 8, 2026, raising $253 million in gross proceeds through the sale of 25,300,000 units at $10.00 per unit, including a full 3,300,000-unit over-allotment exercised by underwriters. Units began trading on the Nasdaq Global Market on January 7, 2026, under the symbol SORNU, with each unit comprising one Class A ordinary share and one-third of one redeemable warrant exercisable at $11.50. BTIG, LLC acted as sole book-running manager, with Reed Smith LLP serving as issuer's counsel. The SPAC's board includes Marc Mazur, Charles N. Khan III, and Spencer Gerrol, alongside Di Rezze and CFO Jamie Weber, with Peter Ondishin and Nicholas Shekerdemian serving as advisors.
Prior to leading Soren Acquisition, Di Rezze served as Chief Legal Officer of Theoria Medical from February 2024 to August 2025. Theoria Medical is a national physician-services platform and one of the largest providers of post-acute care in the United States. She co-founded Theoria Medical and held various roles at the organization before ascending to the chief legal officer position. In addition to her SPAC leadership role, Di Rezze is a Principal at the Di Rezze Family Office, an investment management firm with 11 to 50 employees. She is also the Partner and Founder of Di Rezze & Associates P.C., a corporate-focused law firm built on the principle of providing legal representation to clients in need, emphasizing the value of knowledgeable and trusted counsel in navigating the court system.
Di Rezze holds a Juris Doctor degree, as noted in Reed Smith's advisory announcement of the Soren Acquisition IPO. Her professional activities span law, healthcare, and investment management, reflecting a multifaceted career that bridges legal expertise, operational leadership in physician services, and capital markets activity through the SPAC vehicle. Soren Acquisition Corp. is currently in pre-deal status, with a 24-month tenor to complete a business combination and a stated focus on identifying an attractive target business within the healthcare industry on a global basis. The company's IPO trust account holds 100% of proceeds, and no target company or transaction has yet been announced.
This record is keyed to SEC CIK 0002086310 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 8 institutional-holder rows on these vehicles, under 7 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.